Sonodynamic therapy (SDT), which is based on photodynamic therapy (PDT), is a new cancer treatment modality. Unlike PDT, which has poor tissue penetration, ultrasound can penetrate deeply into tissues and largely target tumor tissue to mediate the cytotoxicity of sonosensitizers. We hypothesize that, similar to PDT, SDT may perform effectively as a cancer vaccine. Thus, we developed a therapeutic strategy to explore whether SDT can eliminate primary tumors, inhibit metastases, and prevent tumor relapse. In the present study, we found that HiPorfin (HPD)- has a stronger penetration ability in biological tissues compared to photons. 6,7 Therefore, sonodynamic therapy (SDT) is considered to be a promising modality for treating malignancies. 8 Non-thermal ultrasound reaches non-superficial objects and focuses on targeted tissues, inducing local cytotoxicity by activating sonosensitizers while minimizing undesirable injury to surrounding normal tissues.
| INTRODUCTION
Cancer is one of the deadliest diseases worldwide. Current therapeutic modalities have enhanced therapeutic effects in patients suffering from cancer; however, the curative effect remains unsatisfactory in patients with advanced cancer. In addition, the high recurrence rate of cancer has driven investigators to explore novel cancer treatment strategies.
Photodynamic therapy (PDT) can effectively eradicate cancer cells by producing reactive oxygen species (ROS) and causing cell apoptosis as a result of the transfer of energy from photons to photosensitizers in tissues.
1 Also, recent studies 2, 3 have shown that tumor cells treated in vitro with PDT can be used to generate potent cancer vaccines. Maturation was induced in dendritic cells (DC), which were activated to express interleukin (IL)-12 by PDT-generated tumor cell lysates. Tumor growth can be inhibited in vitro with a vaccine generated from PDT-treated tumor cells of the same origin. 4 However, poor tissue penetration of PDT has limited its use to superficial lesions. 5 Thus, investigators have sought alternative types of energy that can deeply penetrate tissues. Emerging evidence has indicated that ultrasound-activating sensitizers (sonosensitizers) can significantly damage malignant tumor cells. 6 Meanwhile, ultrasound has a stronger penetration ability in biological tissues compared to photons. 6, 7 Therefore, sonodynamic therapy (SDT) is considered to be a promising modality for treating malignancies. 8 Non-thermal ultrasound reaches non-superficial objects and focuses on targeted tissues, inducing local cytotoxicity by activating sonosensitizers while minimizing undesirable injury to surrounding normal tissues. 6 The most important problem in the development of SDT is the proper choice of parameters that primarily determine its therapeutic efficacy. Currently, experts are exploring a variety of parameters; 9, 10 however, no specific criterion has yet been determined. The choice of ultrasound parameters may be one of the reasons restricting the use of SDT. 11, 12 Satisfactory therapeutic performance cannot be achieved without appropriate parameters.
Recent studies of SDT have shown its effectiveness in killing tumor cells, 13, 14 and a few of these studies have even investigated SDT in clinical practice. 15, 16 However, the antitumor effect of SDT is often limited to tumor growth inhibition instead of tumor shrinkage. 17 Therefore, the question for us is whether tumor shrinkage can be induced if the number of irradiation cycles is increased.
Moreover, although the differences between PDT and SDT are not yet clear, the principles, processes, drugs needed and mechanisms of action of PDT and SDT are similar. Therefore, we hypothesize that similar to tumor cell lysates generated from PDT, SDT-generated tumor cell lysates can elicit an immune reaction against tumor cells of the same origin. However, the establishment of systemic immune memory may be related to the number of cycles of SDT.
Hence, we investigated the effect of SDT applied in 4 or 6 cycles on the induction of systemic immune responses in mice to determine its killing effect on tumor cells and its immunogenicity in tumor-bearing mice.
| MATERIALS AND METHODS

| Sensitizer
HiPorfin (HPD, C34H38N4O6, 598.7, 25 mg/5 mL) was purchased from Huading Modern Bio-pharmaceutical, Co., Ltd (Chongqing, China). Stock solutions at concentrations of 5, 10 and 20 lg/mL were made with normal saline (NS) and kept in the dark at À20°C until use. 
| Cell lines and animals
| Antibodies
The following antibodies were used in this study: anti-calreticulin 
| Ultrasound irradiation system
Ultrasound therapeutic apparatus (Haphel, XK-2011R) was pur- | 1331
| Optimal parameters for SDT
To investigate the efficacy of SDT, the 4 parameters: photosensitizer concentration, ultrasound intensity, irradiation time, and ultrasound frequency, were set at 3 levels (Table 1 ). An orthogonal experimental approach was adopted using these 4 parameters (Table 2) . MTT analysis, cell apoptosis, intracellular ROS in vitro, and anticancer efficacy in vivo were conducted to explore the optimal parameters for SDT. All experiments were carried out avoiding light.
| MTT analysis
Hep3b cells were incubated with HPD (5, 10 or 20 lg/mL 
| Evaluation of in vitro immunogenic cell death
Immunofluorescence and flow cytometry were used to evaluate immunogenic cell death (ICD) induced by SDT. 
| Flow cytometry
Hep3b cells were seeded at 1 9 10 6 cells per well in 6-well plates.
After treatment with SDT and a further 4-hour incubation, the cells Four factors were set at three levels to explore the effects of different combinations. 
| Hematoxylin and eosin staining for pathological analysis
Three randomly chosen mice per group were killed on day 24. Tumors were stained with H&E for histopathological analysis. Livers, lungs, kidneys and hearts excised from the mice were embedded in optimal cutting temperature medium, cut into sections of 4-lm thickness, stained with H&E and observed for toxicity by light microscopy (Panoramic Scan Whole Slide Scanner; Perkin Elmer, Waltham, MA, USA).
| Primary tumor tissue immunohistochemical staining
Excised tumors were fixed in 4% PFA, dehydrated in a graded ethanol series, cleared in dimethylbenzene, and embedded in paraffin.
Tissue blocks were sectioned to 4-lm sections and the sections were mounted on glass slides. Tissue sections were deparaffinized rehydrated, heated in citrate buffer (0.01 mol/L, pH 6.0), and treated with endogenous peroxidase at room temperature. After blocking in 10% goat serum, the sections were stained with primary antibodies against CD4, CD8, CD68, CD163, CD25, and FoxP3, and incubated overnight at 4°C. The sections were incubated with secondary anti- ðexperimental releaseÀspontaneous releaseÞ=ðmaximum release À spontaneous releaseÞ Â 100%:
| Distant tumor tissue immunohistochemical staining
The basic procedures are the same as that for primary tumor tissues.
All sections were stained with CD4, CD8 antibodies and observed
under a positive fluorescence microscope (BX43; Olympus).
Immunopositivity of cells was quantified using IOD values with
Image-Pro Plus 6.0.
| Statistical analysis
Statistical analyses were carried out using SPSS 20.0. Betweengroups differences were compared through analysis of variance (ANOVA), and P < .05 indicated a significant difference.
3 | RESULTS
| Optimal parameters for SDT
Optimal parameters are the foundation for SDT and can maximize therapeutic effects and minimize side-effects. Therefore, we designed experimental schemes based on 4 primary parameters: concentration of photosensitizers (lg/mL), intensity of ultrasound (W/ Relative survival rates of Hep3b cells in the presence of 1 mL HPD and ultrasound irradiation are shown in Figure 2A and Table 1 .
The highest relative survival in Hep3b cells was observed in group 7 at 1.0969 AE 0.4420, and the lowest survival was observed in group 9 at 0.7777 AE 0.8623. Results of univariate analysis indicated significant between-groups differences at various HPD concentrations (P < .001), ultrasound intensities (P = .008), ultrasound frequencies (P = .396) and irradiation times (P = .002). In addition, the efficacy of SDT was affected by the parameters in the following order Generation of ROS is considered the primary mechanism of action of SDT. Therefore, the production of ROS was analyzed with DCFH-DA staining followed by flow cytometry. Compared with that in the negative control group, level of ROS increased in the experimental groups ( Figure 2B,C) . Results of 1-way ANOVA indicated significant differences among groups (P = .004). Univariate analysis showed that the production of ROS was primarily determined by the concentration of HPD (P < .001). For HPD concentration, A 3 was the most effective (ROS = 74.508), and the effects of A 2 and A 3
were markedly different from those of A 1 , whereas there was no significant difference between the effects of A 2 and A 3 . Therefore, the efficacy of SDT is optimal with 20 lg/mL HPD.
To investigate the differences in apoptosis among the various groups, percentage of apoptotic cells was determined through flow cytometry. Results for the 9 experimental groups ( Figure 2D ,E) differed significantly from the results for the control group (P < .001).
All treatments of 9 groups were able to kill more than 95% of the Because of the lack of difference between the third ultrasound frequencies, we used 50% frequency in subsequent experiments. According to orthogonal experimental design method, the 3 levels of the 4 parameters were divided into 9 groups.
To explore the relation between the number of successive irradiation cycles and therapeutic effect, 40 nude mice were randomly divided into 5 groups and irradiated for 0, 1, 2, 3 and 4 cycles.
When the primary tumors reached 100-200 mm 3 in volume, we began irradiation and measured tumor size. Interestingly, tumor size in the group that had been irradiated for 4 cycles was clearly smaller than that in the other groups (P = .001) ( Figure 2F ). Therefore, in subsequent experiments, we used 1.0 W/cm 2 and 50% ultrasound irradiation for 2 hours.
| Investigation of CRT expression
Calreticulin is a distinct marker on the surface of cells undergoing ICD. 18, 19 ICD activate the immune responses through a prominent pathway against cancer cells, which then determines the long-term effect of anticancer therapies. 20 Using flow cytometry ( Figure 3A) and immunofluorescence ( Figure 3B responses. 23 Earlier studies have shown that tumor tissues can secrete Th2 cytokines. In addition, induction of Th2 cytokine production is one of the mechanisms of tumor immune escape. 24 Therefore,
we assessed the serum levels of cytokines in KM mice subjected to SDT and observed a shift from Th1 to Th2 cells. To evaluate the antitumor immunity evoked by SDT and HPD, we collected blood every 3 days from syngeneic tumor-bearing mice, beginning on the first day of HPD injection (day 7 after tumor inoculation) to day 17.
Sera were isolated and analyzed by ELISA to determine the concentration of IFN-c ( Figure 4A ), IL-2 ( Figure 4B ) and IL-10 ( Figure 4C ).
No significant differences were observed in the 3 pro-inflammatory cytokine levels among the control, HPD and ultrasound groups during the experimental period. However, significantly higher levels of IL-2 (P = .001, vs control), IFN-c (P < .0001, vs control) and lower levels of IL-10 (P < .0001, vs control) were observed in mice treated by ultrasound irradiation with HPD on day 10 after continuous irra- (Tables 1 and 2 ) was determined using the MTT assay. B, C, Reactive oxygen species (ROS) levels were measured using dichlorodihydrofluorescein diacetate (DCFH-DA). Fluorescence signals were detected with a FACSVerse flow cytometer. D, E, Apoptotic cell death (Annexin V/propidium iodide [PI] staining) was measured using flow cytometry in the 9 groups of Hep3b cells cotreated with HiPorfin (HPD) and ultrasound. F, Changes in tumor volume in 40 mice. Nude mice bearing s.c. tumors on the right flank were randomly divided into 5 groups and irradiated for 0, 1, 2, 3 and 4 cycles to explore the relationship between the number of irradiation cycles and therapeutic effects (n = 8). Results were calculated and presented as the means AE standard deviation (SD). Student's t tests and ANOVA were carried out, and levels of significance are indicated as *P < .05; **P < .01; and ***P < .001. NC, control group distant (abscopal) tumors. When the primary tumors reached 200~300 mm 2 in volume, the mice were randomly divided into 4 groups. HPD was injected into the animals every 3 days for a total of 6 injections, followed by ultrasound irradiation on primary tumors can be used for the detection of different classes of tumor-associated macrophages (TAM), namely, M1 and M2 (immune-suppressive). 25, 26 In the present study, we chose CD163 and CD68 to identify M2 macrophages and thus observed the effect of SDT on the differentiation of TAM. In addition, regulatory T cells mediating immunoregulation is one of the most important mechanisms for maintaining self-tolerance. When they are induced, they express CD25 and FoxP3. By evaluating the expression of CD25 and FoxP3 in tumor tissues, we identified the effects of SDT on the immune system. As seen in Figure 7A , results showed that the expressions of CD4 and CD8 in the SDT group were increased, which were assessed as moderately positive by immunohistochemistry and as moderate infiltration within tumor issues, whereas no or less tumorinfiltrating CD4 and CD8 were observed in tissues of the other 3 groups. At the same time, CD68 was more highly expressed in the SDT group, whereas CD163 was observed at a lower expression in F I G U R E 6 Abscopal effect of sonodynamic therapy (SDT). A, Bilateral H22 tumor model was made by s.c. injecting cancer cells into the right and left flanks of each animal. Tumors on the left were treated as primary tumors for ultrasound irradiation, and tumors on the right were treated as distant tumors which did not receive ultrasound irradiation. PBS or HiPorfin (HPD) was injected (ip) into the H22 tumor-bearing mice for 4 or 6 cycles, followed by ultrasound irradiation (1.0 W/ cm 2 , 50%, 2 h) 4 h after each injection. B, Tumor growth inhibition curves for H22 xenograft models after 6 treatment cycles (P < .05). Data are expressed as the means AE SD (n = 10) this group compared with the other groups. Expressions of CD25 and FoxP3 followed similar trends to that of CD163.
Immunopositivity of cells was quantified based on IOD values by using Image-Pro Plus 6.0. Results of 1-way ANOVA indicated significant differences between groups (CD4, P < .001; CD8, P < .001; CD68, P < .001; CD163, P = .005; CD25, P < .001; and FoxP3, P < .0001) (Figure 7B -G). Significant differences were observed within groups for the various SDT parameters. Tumor tissues subjected to SDT showed high expression levels of CD4, CD8, and CD68 and low expression levels of CD163, CD25, and FoxP3, which suggested that SDT could activate T cells, promote a shift from M2 to M1 macrophages and induce immune responses. 26 
| Specific immune effect in a murine liver cancer model
Bilateral H22 tumor models in the SDT group showed both primary and distant tumor shrinkage, which suggested that SDT may have elicited an immune response. To further study whether the immune response was specific, we used (LDH) release experiments to evaluate the killing ability of CTL to H22 tumor cells specifically. LDH is an enzyme present in the cell cytoplasm that cannot penetrate the cell membrane under normal conditions. When target cells are attacked by effector cells, the cell membrane is damaged and its permeability is changed, allowing LDH to be released into the media. 27 Through measurements of extracellular LDH, we could evaluate the killing ability and specificity of CTL for each group. Results showed that for H22 tumor cells (Figure 8A ), the ability of CTL cells of the SDT group was obviously higher than that of the other 3 groups (P < .0001). When the E:T ratio was 100:1 (P < .0001), CTL cells had the strongest ability to kill tumor cells. On the contrary, for S180 tumor cells (Figure 8B ), the killing capability of CTL cells showed no significant difference between the 4 groups (P = .123). CD4 and CD8 CTL are important when an immune response is produced. | 1341 (Figure 9 ), which were quantified based on IOD values by using Image-Pro Plus 6.0 (CD4, P < .0001; CD8, P < .0001). Results showed that SDT can cause a specific immune response in mice after treatment, and tumors eventually reduce or disappear.
| H&E staining for pathological analysis
Cytotoxicity, including acute nephrotoxicity, cardiotoxicity and hepatotoxicity, as a result of SDT was assessed by H&E staining to determine the effect of SDT on the kidneys, hearts and livers of mice. In the current study, the groups subjected to 4 or 6 treatments showed normal renal glomeruli ( Figure 10C ), tubules and interstitium, with distinct epithelial cell boundaries in the renal tubule (particularly the proximal tubule). In addition, the liver cells ( Figure 10B and CD8 in distant tumor tissues were found in the SDT group.
LDH release experiments showed that toxicity of CTL cells caused a specific response in H22 cells, but had no effect on S180, which showed that the immune response induced by SDT in mice is speci- T ratio of 100:1, 50:1, and 25:1 were seeded in 96-well plates at 37°C and 5% CO 2 incubator for 4 h. CTL activity was determined by lactate dehydrogenase releasing assay. All the experiments were carried out in triplicate, and the results are presented as the means AE SD (n = 3). t tests and ANOVA were carried out. NC, control group phenotype to regulate immune responses. The progress of SDT exerting a systemic effect is shown in Figure 11 .
Compared with previous studies of SDT, 12,32 our study identified 4 parameters (ie, photosensitizer concentration, ultrasound intensity, irradiation time and ultrasound frequency) using an orthogonal experimental method and optimization of them to maximize the therapeutic effect and to minimize side-effects of SDT. Compared with the current application of SDT, 33 we determined that increasing . t tests and ANOVA were carried out, and the levels of significance for each group vs the sonodynamic therapy (SDT) group are indicated as ***P < .001. NC, control group F I G U R E 1 0 H&E staining for pathological analysis. Cytotoxicity, including acute nephrotoxicity, cardiotoxicity and hepatotoxicity of sonodynamic therapy was assessed by H&E staining to determine the effect on (A) heart, (B) liver and (C) kidney tissues after 6 cycles of treatment (magnification, 409) the number of SDT cycles can improve therapeutic efficacy. We speculate that repeated irradiation during SDT can result in the formation of immune memory in mice, which is the equivalent to vaccination. Compared with conventional studies of SDT, which have shown that SDT kills cancer cells through ROS generation and cavitation effects, 34 we focused on an immune-oriented mechanism of action for SDT that remained unclear until now. Nevertheless, demonstration of the effect of SDT is preliminary, thus the mecha- 
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